Phase 1 PK, Bioavailability, Safety Study of Clonidine MBT w Catapres in Healthy Volunteers

NCT02548806 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Clonidine MBT 50µg
DRUG: Clonidine MBT 100µg
DRUG: Catapres 100μg

Sponsor

Valerio Therapeutics

Collaborators

[object Object]